Ofost (Oxytocin)

Oxytocin, the active ingredient in Ofost, is a oxytocic agent presented as a sterile injectable solution for intramuscular and intravenous use. It is employed to initiate or strengthen uterine contractions during labor and to manage postpartum hemorrhage in pregnant women. It is commonly used under obstetric supervision to facilitate safe delivery outcomes.

GNH USA supplies Ofost as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Ofost (oxytocin) acts on the uterine smooth muscle to promote contraction, making it valuable in obstetric care. - Induction of labor: initiates regular uterine contractions to start the birthing process. - Augmentation of labor: enhances the strength and frequency of contractions to progress labor. - Control of postpartum hemorrhage: increases uterine tone after delivery to reduce bleeding. - Uterine atony: restores contractility of an atonic uterus to prevent excessive blood loss.

Oxytocin may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Uterine hyperstimulation: excessive contraction frequency or intensity. - Nausea and vomiting. - Headache. Serious or Rare Side Effects: - Water intoxication (hyponatremia) from antidiuretic activity. - Myocardial ischemia or infarction. - Anaphylactic reaction.

When using Ofost, careful monitoring and specific safety measures are recommended. - Fetal monitoring: continuous assessment of fetal heart rate is required during use. - Obstetric supervision: administer only under qualified obstetric care. - Cardiovascular disease: use with caution in patients with coronary artery disease or hypertension. - Magnesium sulfate co‑administration: may diminish oxytocin effectiveness; adjust dosing accordingly. - Hypersensitivity: discontinue immediately if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Oxytocin can interact with several medications, affecting its efficacy or safety. Major Interactions (Avoid): - Ergot alkaloids: combined use can cause severe hypertension and uterine rupture. - Magnesium sulfate: may antagonize oxytocin’s uterotonic effect, reducing efficacy. - Vasopressin antagonists: can interfere with oxytocin’s action on uterine smooth muscle. Moderate Interactions (Monitor Closely): - Prostaglandin analogues: additive uterine stimulation may increase risk of hyperstimulation. - Calcium channel blockers: may lessen oxytocin‑induced contractions. - Beta‑adrenergic agonists: may oppose oxytocin’s uterotonic activity.